期刊文献+

阿司匹林在糖尿病患者心血管事件一级预防中的应用价值 被引量:1

下载PDF
导出
摘要 目的探究糖尿病患者应用阿司匹林对心血管事件一级预防所产生的影响。方法 126例糖尿病患者,按照随机分组的方式分为对照组和实验组,每组63例。对照组患者采用安慰剂进行心血管事件预防,实验组患者采用阿司匹林进行心血管事件预防。分析比较两组患者的血清指标水平和心血管意外事件发生情况。结果实验组患者的各项血清指标水平均优于对照组,差异具有统计学意义(P<0.05)。实验组患者的心血管意外事件总发生率11.11%明显低于对照组的30.16%,差异具有统计学意义(P<0.05)。结论阿司匹林用于糖尿病患者心血管事件一级预防中,能够有效改善患者的血清学数值,并且能够降低患者心血管事件的发生,具有良好的临床应用价值,值得推广使用。
作者 杨传梅
出处 《中国实用医药》 2018年第14期120-121,共2页 China Practical Medicine
  • 相关文献

二级参考文献86

  • 1Natarajan A, Zaman AG, Marshall SM. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents. Diab Vasc Dis Res, 2008,5 : 138-144. 被引量:1
  • 2Baigent C, Collins R, Appleby P, et al. ISIS-2:10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of In farct SurvivaDCollaborative Group. BMJ, 1998,316 : 1337 -1343. 被引量:1
  • 3Collaborative overview of randomised trials of antiplatelet therapy- I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ, 1994,308 : 81-106. 被引量:1
  • 4Antrthrombotic Trialists' Coilaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002,324:71-86. 被引量:1
  • 5Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention. Am J Cardiol, 2006,97:38-43. 被引量:1
  • 6Cubbon RM, Gale CP, Rajwani A, et al. Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome. Diabetes care, 2008,31:363-365. 被引量:1
  • 7Angiolillo DJ, Bernardo E, Ramirez C, et al. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol, 2006,48:298- 304. 被引量:1
  • 8Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta- analysis of individual participant data from randomised trials.Lancet, 2009,373:1849-1860. 被引量:1
  • 9Berardis GD, SaccoI M, Graziano G, et al. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis of randomized controlled trials. ADA 69th Scientific Sessions, 2009 : 90-OR. 被引量:1
  • 10Ogawa H, Nakayama M, Morimoto T, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA, 2008, 300: 2134-2141. 被引量:1

共引文献28

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部